HIGHLIGHTS
- who: Safaa M. Ramadan and collaborators from the Currently in the Hemato-oncology Division, European Institute of Oncology, Milan, Italy Currently in the Department of Medical Oncology, NCI-Cairo University, Cairo, Egypt have published the research work: Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials, in the Journal: Cancers 2020, 12, 3334 of 11/Nov/2020
- what: The authors report the outcomes of secondary acute myeloid leukemia (s-AML) patients included in one of 13 European Organisation for Research and Treatment of Cancer (EORTC) collaborative AML trials . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.